SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-045598
Filing Date
2018-07-17
Accepted
2018-07-17 20:48:24
Documents
2
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5787
2 EX-24 ex-24.htm EX-24 9199
  Complete submission text file 0001104659-18-045598.txt   16356
Mailing Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS 325 VASSAR ST., STE. 1A CAMBRIDGE MA 02139
Business Address
NISSEN TORBEN STRAIGHT (Reporting) CIK: 0001746647 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38586 | Film No.: 18957562